An online misadventure with haloperidol [3]

Annals of Pharmacotherapy

Volumn 37, Issue 10, 2003, Pages 1531-

  Barnes Recker, Carrie K ^a   Hoehns, James D ^a   Sutherland, John E ^b   Opheim, Eric F ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NE Iowa Fam Pract Residency Prog ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENTAZEPAM; HALOPERIDOL; LORAZEPAM; METHAMPHETAMINE; PENICILLIN G; TETANUS ANTIBODY;

ADULT; CASE REPORT; DRUG MARKETING; DRUG MISUSE; DRUG SCREENING; DYSTONIA; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; LETTER; MUSCLE SPASM; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; TETANUS;

EID: 0141557868     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1d176     Document Type: Letter

References (5)

1. Hainer M, Tsai N, Komura S, Chiu C. Fatal hepatorenal failure associated with hydrazine sulfate. Ann Intern Med 2000;133:877-80.
2. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
3. FDA letter of citation to Pharma Group: ref no. 01-HFD-310I-130. www.fda.gov/warn/cyber/cyber2001.html (accessed 2002 Aug 29).
4. Rhee S, Hodgkins B, Tsourounis C, Miller T. Pharmacy on the Internet: legal issues and safety concerns. CJHP 1999;11:14-7.
5. FDA Web site with contact information and press releases pertaining to "cyber" warning letters. www.fda.gov/warn/cyber/cyber2002.html (accessed 2002 Aug 28).